Clinical Trials
Merck Announces Results From Phase 3 Studies of ZEPATIER™ in Chronic Hepatitis C Patient Populations at The International Liver Congress™
Merck, known as MSD outside of the United States and Canada, today announced the presentation of results from two Phase 3 clinical trials evaluating...
Research Insight
IMS Health Study: U.S. Drug Spending Growth Reaches 8.5 Percent in 2015
Total spending on medicines in the U.S. reached $310 billion in 2015 on an estimated net price basis, up 8.5 percent from the previous...
Press Releases
Bayer to present latest preclinical data on oncology compounds in 107th Annual Meeting of American Association for Cancer Research
Bayer will present latest preclinical data on oncology compounds, which are currently in preclinical or early clinical development stage at the American Association for...
Industry Reports
Lilly To Provide Detailed Update Of Pipeline And R&D Strategy At Upcoming Investment Community Meeting
Eli Lilly and Company announced it will host a meeting for the investment community, including institutional investors, sell-side analysts, ratings agency representatives, and financial...
News
Pfizer taps IBM for research collaboration
Experimental “Internet of Things” System Uses Connected Devices to Enable Remote Measurement of Health and Quality of Life in Real-Time.Multi-Year Project Could Potentially Change...
News
Novartis’ Sandoz unit receives EC approval
Sandoz, a Novartis division and the global leader in biosimilars, announced that the European Commission (EC) has approved a type II variation for the...
News
Aurobindo Pharma receives USFDA approval for Valganciclovir tablets
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read